ArticleJournal of comparative effectiveness research2021

Cost-effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes.

Margaret F Zupa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.